Monomerization of Viral Entry Inhibitor Griffithsin Elucidates the Relationship between Multivalent Binding to Carbohydrates and anti-HIV Activity  by Moulaei, Tinoush et al.
Structure
ArticleMonomerization of Viral Entry Inhibitor Griffithsin
Elucidates the Relationship between Multivalent
Binding to Carbohydrates and anti-HIV Activity
Tinoush Moulaei,1 Shilpa R. Shenoy,2,3 Barbara Giomarelli,2 Cheryl Thomas,2 James B. McMahon,2 Zbigniew Dauter,4
Barry R. O’Keefe,2,* and Alexander Wlodawer1,*
1Protein Structure Section, Macromolecular Crystallography Laboratory, National Cancer Institute-Frederick, Frederick,
MD 21702-1201, USA
2Molecular Targets Laboratory, Center for Cancer Research, National Cancer Institute-Frederick, Frederick, MD 21702-1201, USA
3SAIC-Frederick Inc., National Cancer Institute, Frederick, MD 21702-1201, USA
4Synchrotron Radiation Research Section, Macromolecular Crystallography Laboratory, National Cancer Institute, Argonne National
Laboratory, Argonne, IL 60439, USA
*Correspondence: okeefeba@mail.nih.gov (B.R.O.), wlodawer@nih.gov (A.W.)
DOI 10.1016/j.str.2010.05.016SUMMARY
Mutations were introduced to the domain-swapped
homodimer of the antiviral lectin griffithsin (GRFT).
Whereas several single and double mutants re-
mained dimeric, insertion of either two or four amino
acids at the dimerization interface resulted in a
monomeric form of the protein (mGRFT). Monomeric
character of the modified proteins was confirmed by
sedimentation equilibrium ultracentrifugation and by
their high resolutionX-ray crystal structures,whereas
their binding to carbohydrates was assessed by
isothermal titration calorimetry. Cell-based antiviral
activity assays utilizing different variants of mGRFT
indicated that the monomeric form of the lectin had
greatly reduced activity against HIV-1, suggesting
that the antiviral activity of GRFT stems from
crosslinking and aggregation of viral particles via
multivalent interactions betweenGRFT and oligosac-
charides present on HIV envelope glycoproteins.
Atomic resolution crystal structure of a complex
between mGRFT and nonamannoside revealed that
a single mGRFT molecule binds to two different non-
amannoside molecules through all three carbohy-
drate-binding sites present on the monomer.
INTRODUCTION
A variety of infections caused by enveloped viruses are currently
the subject of extensive research aimed at discovery and devel-
opment of preventive and therapeutic antiviral agents. In partic-
ular, infections caused by viruses such as HIV, SARS-associated
corona virus, ebola hemorrhagic fever virus, and hepatitis virus
are in need of novel ways of prevention and therapy. One of
the promising, although not well-developed strategies for
combating these viral infections is inhibiting viral entry with
lectins such as cyanovirin-N (CV-N), scytovirin (SVN), or griffith-
sin (GRFT) (Balzarini, 2007). GRFT, originally isolated from1104 Structure 18, 1104–1115, September 8, 2010 ª2010 Elsevier Ltextracts of red alga Griffithsia sp., has demonstrated antiviral
activity against both HIV (Mori et al., 2005) and SARS (O’Keefe
et al., 2010; Zeitlin et al., 2009). It has the most potent activity
of all known lectins against various HIV-1 isolates, with EC50 in
the midpicomolar range. Furthermore, GRFT has been shown
to be amenable to large-scale, agricultural manufacturing
(O’Keefe et al., 2009). The stability and low immunogenicity of
GRFT make it a candidate for formulation as a component of
vaginally or rectally applicable microbicides (Zeitlin et al., 2009).
Earlier work in our laboratories has resulted in elucidation
of the structural, biophysical, and biochemical properties of
GRFT, along with its mode of binding to several mono- and
disaccharides (Giomarelli et al., 2006; Mori et al., 2005; Zio´lkow-
ska et al., 2006, 2007b). However, we were not able to prepare
soluble complexes of GRFT with branched carbohydrates corre-
sponding to those present on viral envelopes, such as a synthetic
nonamannoside or a slightly larger Man9 (Figure 1), since such
complexes precipitated from solution even at very low concen-
tration. For that reason, previously we used molecular modeling
to derive the putative structure of the GRFT-Man9 complex
(Zio´lkowska et al., 2007a). GRFT is a domain-swapped homo-
dimer with the first 16 amino acids of one monomer completing
the b-prism-I fold of the other monomer (Zio´lkowska et al., 2006).
Each monomer comprises one binding surface at opposite ends
of a double-prism homodimer, and each binding surface is
composed of three carbohydrate-binding pockets, for a total of
six binding pockets per GRFT dimer. Still to be answered are
questions about the exact mechanism for the antiviral activity
of GRFT and its mode of binding to high-mannose, branched
carbohydrates. Logical models for the mechanism of GRFT’s
activity include (i) coating of viral particles and blocking
interaction with cell surface receptors, (ii) inhibiting viral entry
postattachment, (iii) aggregation/agglutination of viral envelope
glycoproteins or particles, and (iv) enhancement of the cellular
immune response. One approach to finding answers to these
questions appeared to be through engineering, expression,
and purification of a monomeric form of GRFT (here called
mGRFT). The availability of such a protein was expected to
allow us to directly address the role of multivalency and cross-
linking in GRFT binding to carbohydrates and to elucidate how
these binding interactions relate to antiviral activity. It was alsod All rights reserved
Figure 1. Chemical Structure of the Nona-
mannoside Used in This Study
The three branches are labeled D1–D3, and the
individual mannose moieties are numbered in
a manner consistent with the nomenclature used
for Man9 (Man9GlcNAc2) in the earlier studies
of GRFT binding to branched carbohydrates
(Zio´lkowska et al., 2007a). Man9 differs from the
nonamannoside by replacement of the pentyl
chain by two N-acetyl glucosamines connected
to mannose 3 by a b1-4 linkage. Carbohydrate
residues that bind to one molecule of mGRFT are
red, the residue bound to its symmetry mate is
blue, and the atoms not visible in the electron
densitymap of the complex of the nonamannoside
with 1GS-S are gray.
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Monomerization of Griffithsinanticipated that an antiviral protein of reduced size might exhibit
potentially more advantageous physiological attributes.
We have engineered several variants of mGRFT and studied
their physical properties using ultracentrifugation, isothermal
titration calorimetry, and X-ray crystallography, as well as inves-
tigated their biological activity using anti-HIV infectivity assays.
We found that the monomers were fully capable of binding
carbohydrates, but were less stable thermodynamically than
GRFT and had greatly diminished antiviral activity. The latter
result provides a clue to the mechanism responsible for the anti-
viral activity of GRFT.
RESULTS
Attempts to Create mGRFT by Mutation of Amino Acids
Analysis of the previously solved X-ray crystal structures of
GRFT (Zio´lkowska et al., 2006, 2007b) pointed to several
possible approaches to engineering of mGRFT. Our initial efforts
at creating monomeric GRFT were aimed at stabilizing its hinge
region (residues 15–19) so as to allow the monomeric form to
predominate, and on removing the hydrogen bonded interac-
tions with the N-terminal peptide. We have thus created a series
of mutants, starting from the replacement of Ser65 (whichmakes
a hydrogen bond with the amide group of Gly8) by an aromatic
residue, such as tyrosine or tryptophan. Additional mutations
were made at positions 2 (L2V), 6 (K6V), 106 (S106E), and 119
(E119I), both singly and in combination with the mutation
S65Y. None of these initial attempts resulted in the formation
of monomeric GRFT and the resulting proteins retained their
dimeric character.
Creation of mGRFT by Insertion of Residues
into the Hinge Region (1GS and 2GS)
Another approach to creation of monomeric GRFT relied on
the detailed analysis of the region responsible for domain swap-Structure 18, 1104–1115, September 8, 2010 ªping. The dimerization interface of GRFT
consists of a ‘‘hinge’’ formed by the
swapped strands (containing Ser16 and
Gly17), as well as a ‘‘lock’’ created
by hydrophobic interactions of Leu2,
Ile101, and Tyr117 (Figure 2A). Further-
more, structures of GRFT in complexwith maltose and N-acetylglucosamine (Zio´lkowska et al.,
2007b) contain an ethylene glycol molecule spanning the 7.4 A˚
gap between the swapped strands at the dimerization interface.
We hypothesized that the gap between the swapped strands
can be bridged by insertion of two or more residues between
Ser16 and Gly17, at least one being a serine (to provide polar
interactions similar to those of ethylene glycol). Additionally,
sequences containing GS are commonly found in natural linkers
(Lubkowski et al., 1999); thus, we selected either one or two of
these dipeptides in designing mGRFT.
Both constructs, here called 1GS and 2GS, were successfully
expressed, purified, and crystallized. Their predominantly mono-
meric nature at lower concentrations was initially confirmed
with analytical ultracentrifugation. The dissociation constants
of 1GS and 2GS calculated by sedimentation equilibrium
ultracentrifugation (SEU) were 0.12 and 1.17 mM, respectively.
The weight-averaged molecular mass obtained using a single-
species model was 15.96 ± 0.05 kDa and 15.11 ± 0.08 kDa
for the 1GS and 2GS mutants, respectively. These data can be
interpreted as showing limited self-association of monomers
that does not involve domain swapping.
The 1GS protein crystallized in the space group P61 with
a monomer in the asymmetric unit and its structure was solved
at the resolution of 1.1 A˚ (Table 1). Each of the three carbohy-
drate binding pockets of this form of mGRFT was occupied by
molecules present in the crystallization and cryoprotection solu-
tions. Pocket 1 (Zio´lkowska et al., 2006), adjacent to Asp112,
contained a glycerol molecule. Pocket 2, near Asp30, was filled
by the terminal carboxylate group belonging to a symmetry-
related molecule (Figure 2B), whereas pocket 3, near Asp70,
contained two water molecules. The 2GS mGRFT crystallized
in the space group P6522 and the structure was solved at
1.7 A˚ (Table 1). Each of the potential carbohydrate-binding
pockets contained a glycerol molecule. Electron density for the
inserted sequences on both of these mGRFT molecules were2010 Elsevier Ltd All rights reserved 1105
Figure 2. Structural Features of griffithsin
(A) Dimerization interface of GRFT. Individual monomers are shown in blue and
gray. The hinge region of the swapped strands is shown in the dashed rect-
angle with the glycerol molecule seen in two structures colored in cyan. The
lock region is shown in the dashed oval with the relevant hydrophobic residues
(L2, I101, and Y117) from both chains in stick configuration. All mutations other
than the insertions at the hinge region relevant to this study are mapped onto
the gray monomer. Successful and unsuccessful mutants are colored green
and red, respectively, on the chain and labels. Positions that yielded mixed
results are colored orange on the chain.
(B) Carbohydrate binding surface of mGRFT (1GS). The relative orientation and
interaction of two symmetry related molecules (green and yellow) are shown
with the C-terminal residues of one monomer in stick configuration. Hydrogen
bonds that stabilize Y121 are shown in black dashed lines. Water (red sphere)
and glycerol (gray) molecules in adjacent carbohydrate binding pockets are
shown for the yellow molecule.
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Monomerization of Griffithsinclearly seen in the jFoj-jFcj maps (Figure 3). As predicted, these
insertions led to formation of loops, allowing the first 16 amino
acids to complete the b-prism fold of the same molecule.
Increasing Monomerization and Sensitivity to TEV
Protease (1GS-S)
To facilitate monomerization we also reduced the interactions at
the hydrophobic patch opposite to the strand swap region (the
lock) by creating the L2S variant of the 1GS mGRFT (hereon
called 1GS-S). An unexpected result of the L2S mutation was
that the N terminus of mGRFT was dramatically more suscep-
tible to cleavage by TEV protease (Phan et al., 2002) for the1106 Structure 18, 1104–1115, September 8, 2010 ª2010 Elsevier Ltremoval of the N-terminal hexahistadine affinity tag (Parks
et al., 1994) (not shown). Because of the ease of its purification,
this mutant was used for crystallization of theMan9 complex and
for titration isothermal calorimetry studies. This mutant was
uniformly monomeric with a weight-averaged molecular mass
obtained for this mutant by SEU analysis of 11.58 ± 0.11 kDa.
Elimination of Residual Monomer-Monomer
Interactions (1GS-SDNDY)
Crystal packing of the 1GS variant of mGRFT was such that the
C terminus of one molecule of mGRFT was bound into the
carbohydrate binding pocket 2 of an adjacent mGRFT molecule
(Figure 2B). In order to eliminate this interaction we mutated the
C terminus of 1GS-S, changing its sequence from EQY to DN
(hereon referred to as 1GS-SDNDY). The stability of this mutant
was reduced (see Table 2 available online) and its weight-
averaged molecular mass appeared to be the lowest of all
mGRFT mutants (11.03 ± 0.99 kDa). 1GS-SDNDY crystallized
in the space group P3121 and, although the crystals still dif-
fracted to atomic resolution, showed a high degree of disorder
in the carbohydrate-binding surface, with two binding pockets
containing only water molecules and the third one incorporating
the guanidinium moiety from Arg80 of a symmetry-related
molecule, along with a chloride ion. The chloride ion mediates
most of the interactions between the symmetry-related Arg80
and the binding pocket.
Structure of 1GS-S in Complex with Nanomannoside
(1GS-Sm9)
Crystallization trials of 1GS-S in the presence of nonamannoside
resulted in the growth of crystals under a wide range of condi-
tions. However, regardless of the crystallization conditions, all
tested crystals were isomorphous in the tetragonal space
group I41. Diffraction data were obtained at a resolution of
0.97 A˚ (Table 1). The electron density maps show very clearly
that the complex was formed, delineating unambiguously the
position of the D1 and D2 branches of the nonamannoside
(Figure 4A) and of the two connecting b-mannoses. The density
was partial and weak in the region where mannose 5 of the D3
branch would be expected. The binding mode of nonamanno-
side to 1GS-S is different in some important respects from our
previous computational model (Zio´lkowska et al., 2007a), or
from the recently proposed mode of binding of Man9 to actino-
hivin, a lectin isolated from Longispora albida which is also
presumed to contain three carbohydrate-binding pockets
creating an equilateral triangle (Tanaka et al., 2009). The terminal
mannose 11 of the D1 branch andmannose 8 of the D2 branch of
the nonamannoside bind into two pockets of 1GS-S (pockets 3
and 1 according to the previously introduced nomenclature;
Zio´lkowska et al., 2006), with the rest of the nonamannoside
molecule spanning an arch between these two binding pockets.
In addition, binding pocket 2 is occupied by mannose 7 of the
D2 branch of a symmetry-related nonamannoside molecule,
and hence the overall ratio between polysaccharide and lectin
is still one to one. The weight-averaged molecular mass of the
nonamannoside-saturated complex was 16.73 ± 0.13 kDa, sug-
gesting a two-to-one ratio of nonamannoside to 1GS-S in solu-
tion. This apparent stoichiometric ambiguity can be explained
by the difference in the primary structure of the three bindingd All rights reserved
Table 1. Data Collection and Refinement Statistics
1GS 2GS 1GS-SDNDY 1GS-Sm9
Data Collection
Space group P61 P6522 P3121 I41
Cell dimensions
a, b, c (A˚) 48.6, 48.6, 94.2 55.1, 55.1, 156.7 55.4, 55.4, 61.8 90.5, 90.5, 27.8
a, b, g () 90, 90, 120 90, 90, 120 90, 90, 120 90, 90, 90
Resolution (A˚) 30–1.10 (1.12–1.10) 30–1.70 (1.76–1.70) 30–0.97 (1.00–0.97) 30–0.97 (1.00–0.97)
Rmerge 6.3 (58.3) 9.0 (69.0) 8.2 (78.0) 5.5 (50.7)
I / sI 28.8 (2.0) 24.4 (2.1) 24.2 (2.0) 27.6 (2.0)
Completeness (%) 97.9 (99.7) 97.9 (93.5) 99.9 (99.4) 99.8 (98.4)
Redundancy 6.2 (3.5) 11.4 (5.7) 7.1 (5.2) 4.8 (3.4)
Refinement
Resolution (A˚) 30-1.11 30-1.70 30-0.97 30-0.97
No. reflections 47848 15073 64277 65888
Rwork/Rfree 15.87/15.90 18.39/21.02 15.16/16.50 14.34/15.46
No. atoms
Protein 942 934 1020 933
Ligand/ion 41 29 1 122
Water 117 135 146 165
B-factors
Protein 14.73 18.42 12.57 12.40
Ligand/ion 23.12 25.90 10.23 19.68
Water 31.11 31.10 25.47 27.99
Rmsd
Bond lengths (A˚) 0.020 0.020 0.018 0.020
Bond angles () 1.967 1.875 2.304 2.579
3LKY 3LL0 3LL1 3LL2
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Monomerization of Griffithsinpockets. Tyrosines 27, 68, and 110 form the internal walls of the
mannose-binding pockets and create an almost perfectly
symmetric triangle at the center of the binding surface. The
preceding residues are Asp67 and Asp109 in pockets 3 and 1,
respectively, whereas Ser26 forms part of pocket 2. This differ-
ence in primary structure leads to significant alteration of the
electrostatic landscape of the carbohydrate-binding surface
(Figure 4B). Whereas the surface potential is highly negative in
pockets 1 and 3, it is much less negative in pocket 2. In addition,
Asp67 and Asp109 are both within hydrogen bond distance fromStructure 18, 1104–11the nonamannoside, while Ser26 in pocket 2 is too far to
contribute to binding. It is thus likely that pockets 1 and 3 offer
better binding to the terminal mannoses of two branches of non-
amannoside, while pocket 2 is occupied more transiently. It can
be postulated that when this site becomes temporarily occupied
by b-mannose 7 of a nonamannoside bound to another protein
molecule, the resulting symmetric interactions lead to creation
of a stable crystal lattice, which ultimately changes the apparent
stoichiometry of the complexes. These results point out that the
originally proposed model in which only the terminal mannosesFigure 3. Superposition of the Monomeric
1GS and 2GS Constructs of mGRFT,
Showing the Area of the Dimerization/Inser-
tion Region
Bonds involving carbon atoms of 1GS are
rendered in green and those of 2GS in cyan, with
both inserts in yellow. The omit maps, contoured
at 2.5 s, are red and blue for 1GS and 2GS,
respectively.
15, September 8, 2010 ª2010 Elsevier Ltd All rights reserved 1107
Table 2. Comparison of the Thermodynamic Binding Parameters of GRFT and 1GS-S
Affinity (mM) DH (kcal/mol) DG (kcal/mol) TDS (kcal/mol)
Mannosea GRFT 102.0 ± 13.0 –0.081 ± 0.002 –5.53 ± 0.08 5.54 ± 0.08
1/2a-
mannobiose
GRFT 53.9 ± 6.6 –0.173 ± 0.003 –5.91 ± 0.07 5.74 ± 0.07
1GS-S 55.9 ± 14.3 –0.292 ± 0.012 –5.80 ± 0.21 5.50 ± 0.21
1/3a-
mannobiose
GRFT 50.5 ± 8.3 –0.169 ± 0.005 –5.95 ± 0.10 5.76 ± 0.10
1GS-S 46.1 ± 8.4 –0.310 ± 0.008 –5.91 ± 0.13 5.60 ± 0.13
1/6a-
mannobiosea
GRFT 83.3 ± 17.5 –0.072 ± 0.002 –5.65 ± 0.12 5.58 ± 0.12
1GS-S 84.7 ± 13.7 –0.202 ± 0.008 –5.55 ± 0.09 5.35 ± 0.09
Mannopentaose GRFT 18.9 ± 2.8 –1.20 ± 0.14 –6.54 ± 0.88 5.35 ± 0.14
1GS-S 15.1 ± 1.3 –1.83 ± 0.05 –6.57 ± 0.05 4.74 ± 0.05
Nonamannoside GRFT 0.50 ± 0.16 –13.50 ± 0.11 –8.73 ± 0.31 –4.75 ± 0.31
1GS-S 0.51 ± 0.22 –11.70 ± 1.73 –8.58 ± 0.56 –3.08 ± 1.10
gp120a GRFT 0.008 ± 0.004 –30.40 ± 0.26 –11.20 ± 0.28 –19.16 ± 0.28
1GS-S 0.112 ± 0.050 –35.50 ± 0.56 –9.47 ± 0.68 –25.99 ± 0.67
a Previously published (O’Keefe et al., 2010; Zio´lkowska et al., 2007b; Zio´lkowska et al., 2007a).
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Monomerization of Griffithsinof each branch bound to a single molecule of GRFT (Zio´lkowska
et al., 2007a) was most likely oversimplified, with the observed
mode of crosslinking being only one of many that lead to preven-
tion of the viral entry by this class of lectins.
Differential Scanning Calorimetry
To further quantitate the GRFT monomerization process, the
thermal stabilities of the GRFT monomer variants were studied
using differential scanning calorimetry (DSC). Here, the heat-
capacity change upon unfolding was monitored with respect to
temperature, and the extrapolated midpoint of the transition,
the melting temperature (Tm), and integrated area under the
curve, the enthalpy of unfolding (DHunf), were obtained (Table 3).
Dimeric GRFT melted at a Tm of 78.82
C, with an enthalpy of
unfolding (DHunf) corresponding to 248 kcal/mol (Table 3). The
1GS mGRFT construct, where a GS sequence was introduced
between Ser16 and Gly17, melted at a dramatically decreased
Tm of 67.33
C and DHunf of 91 kcal/mol. Insertion of two GS
sequences in the 2GS GRFT construct resulted in a similar
unfolding as observed in the 1GS construct. The 2GS GRFT
appeared to have greater conformational stability (DHunf =
125 kcal/mol), although it melted at a temperature about
a degree less than its 1GS counterpart. The 1GS-S GRFTmelted
at an even further reduced Tm of 63.48
C and appeared to have
an almost 2-fold greater structural stability (DHunf = 163 kcal/mol)
compared with 1GS, suggesting that the L2Smutation increased
the monomerization potential while stabilizing the overall
domain structure of the protein (Table 3). Last, and in complete
agreement with the analytical ultracentrifugation experiments,
the elimination of residual monomer-monomer interactions
in the 1GS-SDNDY was corroborated in the DSC experiments,
this protein melting at the lowest temperature (Tm = 51.34C)
of all the tested variants of mGRFT. The enthalpy of unfolding
of 1GS-SDNDY GRFT was integrated as 117 kcal/mol, and the
DDHunf = 46 kcal/mol, between this monomer variant and the
1GS-S mGRFT, pointed to possible intermolecular monomer-
monomer contacts that stabilized the 1GS-S but were missing
in the 1GS-SDNDY construct.1108 Structure 18, 1104–1115, September 8, 2010 ª2010 Elsevier LtIsothermal Titration Calorimetry
We previously used isothermal titration calorimetry (ITC) to
characterize the thermodynamics of binding of GRFT to mono-
and disaccharides and showed that the protein preferentially
binds to mannose and mannose-containing sugars (Zio´lkowska
et al., 2006, 2007b). We have extended this analysis here to
study larger branched oligomannose polysaccharides to derive
a more biologically relevant model for the antiviral activity of
griffithsin. A panel of linear and branched oligomannose sugars
was assembled and their binding to dimeric GRFT and to the
1GS-S mutant was examined and compared using isothermal
titration calorimetry (ITC). The derived thermodynamic binding
parameters are shown in Table 2.
In terms of energetics, all interactions observed between the
sugars and the proteins were exothermic, indicating favorable
binding contacts. In addition, entropically favored bindings
(positive TDS values) weremediated by all carbohydrates except
for the nonamannoside, suggesting that the conformational
entropy of the sugars (mannose, mannobioses, and mannopen-
taoses) and/or of the protein regions at the binding interface
were not compromised during complex formation. Among the
dimannoses, 1/6a mannobiose was the weakest GRFT bind-
ing partner with a Kd value almost twice that of the other disac-
charides and with very slight enthalpy contributions. Unlike the
1/6a dimannose (Zio´lkowska et al., 2007a), the 1/2a diman-
nose and 1/3a dimannose bound GRFT with a 2-fold better
binding affinity as compared with mannose alone, pointing to
the importance of proper presentation of the terminal mannoses
in the tested sugars. The enthalpy values among the mannobio-
ses also pointed to possible differences in complex formation
between monomeric and dimeric forms of GRFT, the sugars
appearing to mediate more contacts with the mGRFT protein
(negative DH), although crystal structures of dGRFT (Zio´lkowska
et al., 2006) and mGRFT showed nearly identical integration of
the sugar hydroxyl and carbon backbones within the protein’s
binding sites. Since in ITC experiments the binding interactions
were studied in solution, naturally the results would report all
global and dynamic effects of complex formation, the proteinsd All rights reserved
Figure 4. Binding of Nonamannoside to the
1GS-S Construct of GRFT
(A) Stereo view of the complex of nonamannoside
and 1GS-S. One molecule of nonamannoside
(yellow) bridges carbohydrate-binding pockets 1
and 3, whereas a symmetry-related molecule of
nonamannoside (gray) binds into pocket 2. The
b-mannose monomers bound in the binding
pockets are numbered as in Figure 1.
(B) Computed surface electrostatic potential of
1GS-S monomer (space filling representation)
colored by charge from negative (red) to positive
(blue), with bound nonamannosides shown as
sticks. One nonamannoside molecule (yellow)
binds to two carbohydrate-binding pockets, with
negative electrostatic potential due principally to
Asp67 and Asp109. The second nonamannoside
molecule (gray) binds to the third binding pocket
formed in part by Ser26 instead of Asp in the
equivalent position and carrying a more positive
electrostatic potential.
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Monomerization of Griffithsinand sugars freely tumbling and accessing varying conforma-
tional states of their binding partner. Thus, according to the
calorimetric data with mGRFT, the sugars appeared to access
more surface area contacts that were probably precluded in
the dimer structure due to tumbling or steric effects. However,
these slight differences in binding enthalpy did not amount to a
corresponding difference in binding affinity, suggesting that the
increased surface area contacts with mGRFT were nonspecific
in nature, and indeed the monomeric and dimeric forms of theStructure 18, 1104–1115, September 8, 2010 ªprotein exhibited marked similarities in
binding to any particular sugar (Table 2).
As seen in Table 2, a significant shift in
affinity (and enthalpy) occurred when
the GRFT proteins were titrated with
branched oligomannoses (mannopen-
taose and nonamannoside). Compared
with the dimannose titration experiments,
titrations of GRFT and mGRFT with
mannopentaose resulted in a 3-fold
increase in affinity, presumably due to
the three terminal nonreducingmannoses
of the mannopentaose. However, the
6-fold increase in enthalpy could not be
accounted for by a simple additive en-
thalpic contribution of the exposed ter-
minal mannoses in the mannopentaose
(DHmannopentaose > > 2DHa1,3 dimannose +
DHa1,6 dimannose), suggesting that chemi-
cally equivalent nonreducing mannoses
in the context of a branched sugar struc-
ture (mannopentaose) yielded better
binding contacts and better binding
affinity with GRFT as compared with the
linear dimannoses. In the absence of
a crystal structure of this branched sugar
withGRFT, it is unclear how these terminal
mannoses occupy the sugar bindingsites. However, from examining the entropy of binding it was
apparent that crosslinking of proteins by the mannopentaose
did not occur, as this thermodynamic parameter remained
favorable (Table 2, positive TDS). Similar to the dimannoses,
the mannopentaose appeared to mediate more contacts with
the mGRFT protein (negative DH) than with dGRFT.
In the nonamannoside titrations of GRFT and mGRFT, more
than a 100-fold increase in affinity over the dimannoses, and
more than a 30-fold increase in affinity over the mannopentaose2010 Elsevier Ltd All rights reserved 1109
Table 3. Thermal Stability of GRFT and mGRFT Constructs as
Determined by DSC
Tm (C) DH (kcal/mol)
GRFT 78.82 ± 0.03 248 ± 2
1GS 67.33 ± 0.06 91 ± 2
2GS 66.42 ± 0.05 125 ± 2
1GS-S 63.48 ± 0.06 163 ± 3
1GS-SDNDY 51.34 ± 0.04 117 ± 1
Table 4. Anti-HIV Activity of GRFT Mutants
Sample EC50 (nM) Form
GRFT <0.2 Dimer
S65W <0.3 Dimer
S65Y/S106E <0.2 Dimer
S65Y/E119I 0.5 Dimer
S65Y/K6V 0.4 Dimer
S65Y/L2V 0.5 Dimer
1GS 7 Monomer
2GS 17 Monomer
1GS-S 323 Monomer
1GS-SDNDY 305 Monomer
Structure
Monomerization of Griffithsinwas measured (Table 2). In terms of energetics, the bindings
were largely enthalpically driven (negative DH; DG = DH –
TDS), with 50-fold increase in enthalpy over the dimannoses,
and an approximate 10-fold increase in enthalpy over the man-
nopentaose. Such an increase in enthalpy indicated the pres-
ence of numerous favorable contacts between the sugar and
the protein, in addition to those mediated by the sugar-binding
pockets. This was suggested by the observed crystallographic
results (Figure 4) that showed how a single nonamannoside
molecule spanned an arch of 15 A˚ on 1GS-S mGRFT. The
expanse of protein surface area bridged by the sugar could
have allowed the two binding partners to come close enough
together to mediate multiple, short-distance contacts to
account for the large increase in enthalpy observed in the
calorimetry experiments. Moreover, the observed calorimetric
stoichiometry of two nonamannosides bound per mGRFT (data
not shown) indicated multisite binding and additionally sup-
ported analytical ultracentrifugation experiments which showed
a weighted average of 16.73 kDa for the nonamannoside-
mGRFT complex and which suggested that, on average and in
solution, two molecules of nonamannoside were bound to one
molecule of 1GS-S mGRFT. Where the binding entropy of the
smaller sugars was favorable, the unfavorable binding entropy
(negative TDS) of nonamannoside-GRFT complex strongly
suggested that nonamannoside acted as a multivalent ligand,
binding separate protein molecules and greatly limiting the
conformational freedoms of both binding partners as well as
potentially trapping more water molecules and further reducing
the entropy of the system. The calorimetry data, taken together
with the crystallographic structures and the analytical ultracen-
trifugation data, indicated that the multisite binding by GRFT
and the multivalent binding mediated by the nonamannoside
contributed to the tight affinity/avidity of the binding system.
The avidity of the multisite, multivalent interaction between
GRFT and nonamannoside was also seen in dynamic light
scattering experiments (data not shown) where the percent
polydispersity indicated the presence of multiple species
ranging from monomer to higher combinations of the protein
and oligosaccharide.
The ability of the mGRFT and dGRFT molecules to mediate
multisite, multivalent interactions with oligomannoses was next
tested in experiments with HIV-1 glycoprotein gp120, which
contains multiple high-mannose oligosaccharides believed to
be the recognition elements of antiviral proteins such as griffith-
sin and cyanovirin-N. Previously, the antiviral lectin cyanovirin-N
(CV-N), which has two carbohydrate-binding domains, has been
shown to be able to simultaneously bind to both HIV gp120 and
gp41 (O’Keefe et al., 2000). This interaction was later shown to1110 Structure 18, 1104–1115, September 8, 2010 ª2010 Elsevier Ltbe due to specific multivalent interactions between CV-N and
high mannose oligosaccharides on the surface of HIV envelope
glycoproteins (Shenoy et al., 2001). Thus, it was reasonable to
investigate the effect thatmultivalencymight play in the carbohy-
drate-binding and biological activity of both mGRFT (with three
unidirectional binding sites) and dGRFT (with a bidirectional
composition of six binding sites) with gp120. As can be seen
from the results of the ITC experiments (Table 2), dGRFT shows
approximately 15-fold greater affinity for gp120 than mGRFT.
This difference in measured affinity is likely more related to
a change in avidity resulting from the decreased off-rate of
dGRFT (which caused significant precipitation of gp120 in solu-
tion) as compared with mGRFT (which did not cause similar
precipitates). This result was additionally supported by dynamic
light scattering experiments (data not shown) which showed
the dGRFT-gp120 complex to be fully precipitated, whereas
the mGRFT-gp120 complex to be in a fluid, transitory, and
fully soluble system composed of a number of differently
sized species. Hence, the reduction in crosslinking of HIV
envelope glycoproteins by the more limited carbohydrate-
binding interface of mGRFT, as evidenced by the lack of precip-
itates, resulted in a significant reduction in the measured affinity/
avidity of this molecule for gp120. The functional relevance of
this lack of crosslinking on antiviral activity was further investi-
gated via assessment of the anti-HIV activity of the various
GRFT mutants.
Cell-Based Anti-HIV Activity Assay
To assess the antiviral activity of the various mutant forms of
GRFT, we utilized a previously described assay that measures
the cytopathic effect of HIV infection on T-lymphoblastic cells
(Gulakowski et al., 1991). Nine different mutant forms of
griffithsin were tested for their activity in protecting CEM-SS
cells from HIV. As can be seen in Table 4, dGRFT was potently
active against HIV with and EC50 < 0.2 nM. Several additional
mutants made in the effort to design an obligate monomeric
from of GRFT were also tested. The mutant forms of GRFT
which did not form monomers (S65W, S65W/S106E, E119I/
S65Y, K6V/S65Y, L2V/S65Y) retained potent anti-HIV activity
with EC50 values below 1 nM. However, all monomeric forms
of GRFT exhibited severely diminished anti-HIV activity. Interest-
ingly, such activity seems to be directly correlated to the thermal
stability of the mutants and inversely correlated to theird All rights reserved
Structure
Monomerization of Griffithsinpropensity to self-aggregate (Tables 3 and 4). HIV-1 gp120 has
been estimated to bear 24 N-linked oligosaccharides of which
11 are high mannose (Zhang et al., 2004). As our ITC results
have shown that the binding affinity of GRFT and mGRFT for
branched high-mannose oligosaccharides are essentially iden-
tical, the antiviral results argue for the conclusion that it is the
crosslinking of these oligosaccharides on individual or close
neighbor gp120 molecules that results in the striking antiviral
activity displayed by GRFT.
DISCUSSION
Analysis of the previously published crystal structures of GRFT
(Zio´lkowska et al., 2006, 2007a, 2007b) has led us to a conclusion
that this protein should be considered as ‘‘a candidate for
domain swapping,’’ as defined by Schlunegger et al. (1997).
Unlike in the case of true domain-swapped proteins, there was
no previous indication of the existence of a monomeric form of
this lectin, although the general fold of GRFT is the same as of
the members of jacalin family (Bourne et al., 2002). Whereas
jacalin and related proteins have been shown to form oligomers,
none of them make domain-swapped dimers (Zio´lkowska and
Wlodawer, 2006). However, the reported dimeric nature of
banana lectin (Meagher et al., 2005; Singh et al., 2005) may be
related to its comparatively high antiviral activity (Swanson
et al., 2010). It has been also pointed out that other known anti-
viral lectins, such as CV-N (Bewley et al., 1998) and SVN (Moulaei
et al., 2007), form at least quasidimers (Botos and Wlodawer,
2005). Domain-swapped dimers and a variety of multimeric
forms have been reported for the members of the structurally
unrelated b-prism-II family (Chandra et al., 1999) and served as
a basis of evaluating multivalency of binding to carbohydrates,
using molecular modeling (Ramachandraiah et al., 2003). Crea-
tion of a monomeric form of GRFT was considered by us as
a step in the direction of correlating the quaternary structure of
the antiviral lectins with their biological activity, but the success-
ful engineering of mGRFT also yielded an unexpected benefit of
allowing a crystallographic study of a complex of this protein with
the branched carbohydrate nonamannoside. The latter results
form the basis of a proposed model that explains the role of
multivalency of carbohydrate binding on the antiviral activity of
b-prism-I family.
Initial attempts at forming stable monomers of GRFT centered
on stabilizing the hinge region in GRFT that provides the flexibility
necessary for domain swapping, as well as on preventing
hydrogen bonding between the N-terminal peptide and the
body of the protein. These mutants, involving aromatic substitu-
tions of Ser65, and sometimes additional 1–2 amino acids, did
not have the desired effect and thus an alternative approach
was necessary. A clue to the best way of designing mGRFT
was provided by the presence of a glycol molecule in the vicinity
of residues 16 and 170 (Zio´lkowska et al., 2007b), suggesting
a path for their connection. Similarly to the case of an engineered
Cro monomer (Albright et al., 1996), it appeared that insertion of
two or more residues into the hinge region might prevent domain
swapping and result in a monomeric form of GRFT. Whereas
utilization of a string consisting of five different residues (DGEVK)
led to engineered monomeric Cro, it was sufficient for GRFT to
insert only one or two repeats of the sequence GS, frequentlyStructure 18, 1104–11found in linking regions of proteins due to its flexibility (Lubkow-
ski et al., 1999).
Both the 1GS and 2GS constructs yielded stable lectins, with
almost identical thermal stability as judged by their melting
temperatures of 67C (Table 3). Interestingly, both constructs
were less stable than the dimeric GRFT, and several additional
mutations destabilized them even further. The most telling of
these additional mutations were the 1GS-S and 1GS-SDNDY
forms that resulted in melting temperature of 63 and 51C,
respectively, a loss of up to 27 of thermal stability compared
with GRFT. The results of the DSC studies suggest that themuta-
tions necessary to form true monomeric GRFT result, in this
instance, in a less stable protein. These studies were followed
up with experiments designed to assess the effect of nonaman-
noside binding on the stability of both GRFT and various mGRFT
mutants. As shown in Table 3, although GRFT shows no change
in stability coincident with carbohydrate binding, mGRFT
showed a definite increase in thermal stability upon binding to
nonamannoside. With the overall reduced thermal stability of
mGRFT compared with GRFT, the increase in melting tempera-
ture upon binding nonamannoside is suggestive of conforma-
tional changes leading to such enhanced stability.
Not surprisingly, in isothermal titration calorimetry experi-
ments both the monomeric and dimeric forms of GRFT exhibited
similar affinity to disaccharides, pentamannoside, and virtually
identical avidity of binding to the branched oligosaccharide non-
amannoside. The progression of both binding enthalpies and
dissociation constants indicates that both GRFT and mGRFT
share similar binding interfaces to carbohydrates. What is telling,
however, is the significant increase in the strength of the binding
interaction when one moves from likely single-site binding
interactions (i.e., mannobioses) to those that potentially involve
multiple binding sites on individual GRFT monomers (e.g.,
pentamannoside and, to a greater degree, nonamannoside).
Despite the similarity of their interactions with isolated oligosac-
charides, the binding of GRFT and mGRFT to the viral envelope
protein gp120 differed significantly, with the avidity of mGRFT
being approximately 15-fold lower. Another major difference
was observed in their antiviral properties, with GRFT exhibiting
EC50 of <0.2 nM, whereas the activity of mGRFT was
reduced by three orders of magnitude under similar conditions
(EC50 of 323 nM). This observation is in agreement with the
results reported for the monomeric and dimeric forms of CV-N,
where the presence of at least two binding sites, whether located
on a single molecule or on two molecules, was shown to be
necessary to for their antiviral properties (Liu et al., 2009).
Furthermore, the activity of CV-N mutants that were inactive as
monomers was restored by their dimerization (Matei et al.,
2010). However, another quasidimeric lectin, SVN, behaves
in a different way, since even just its N-terminal domain (SD1)
exhibits significant antiviral properties (Xiong et al., 2006).
It should be noted that several other mutants of GRFT created
for this study did not show either decreased antiviral activity or
true monomeric character. The antiviral assay and thermody-
namic results described here detail the close association of
multivalent interactions between dGRFT and gp120 with its
antiviral activity. The significant reduction in the affinity of
mGRFT for gp120 is mirrored by its drastic reduction in antiviral
activity. The results showing that both dGRFT and mGRFT bind15, September 8, 2010 ª2010 Elsevier Ltd All rights reserved 1111
Structure
Monomerization of Griffithsinwith similar enthalpies and dissociation constants to the Man9
analog nonamannoside indicate that the interactions between
individual high mannose oligosaccharide moieties and individual
monomeric units of GRFT are not sufficient to engender signifi-
cant antiviral activity. It is only in the crosslinking of multiple
high-mannose oligosaccharides present on gp120 when the
carbohydrate-binding capabilities of lectins such as GRFT
confer an antiviral effect. These results further explain our
previous results which detailed the large difference in anti-HIV
EC50 values for a number of monovalent and multivalent mono-
saccharide-specific lectins (Zio´lkowska et al., 2007b).
The ability to grow crystals of the complex of mGRFT with
nonamannoside provides an indirect evidence of the most likely
mode of the antiviral activity of GRFT. All previous attempts to
grow crystals of the complexes of GRFT with Man9 or nona-
mannoside failed due to precipitation of the material from solu-
tion (T.M. and A.W., unpublished data). This was the case even
when both components were mixed at very low concentration
and then concentrated. These results indicate that the activity
of GRFT might be compared with that of an antibody, which
requires the presence of dimers in order to crosslink the anti-
gens. Whereas the absence of such crosslinking would not
influence carbohydrate binding, it would abolish the ability to
interfere with viral infection. A similar explanation of the basis
of antiviral activity was also recently proposed for CV-N (Matei
et al., 2010).
The mode of binding of nonamannoside to mGRFT seen in the
crystals was quite unexpected and did not correspond fully to
the previously published model of their interactions (Zio´lkowska
et al., 2007a). The model structure assumed that the three
terminal mannoses of branches D1-D3 of the nonamannoside
would each occupy sites 1–3 on a GRFT monomer (as defined
by Zio´lkowska et al., 2006), whereas the remaining mannoses
would participate in only limited or no interactions. In agreement
with that model, we found that in the crystals of mGRFT one
nonamannoside molecule inserts its mannose 11 from the D1
branch into site 3 on the protein, whereas mannose 8, terminal
in branch D2, is located in site 1. However, it is mannose 7, the
second unit on the D2 branch from a symmetry-related nona-
mannoside molecule, that is located in site 2 of mGRFT. It is
very likely that this mode of binding is a crystallization artifact,
which, incidentally, must have helped in the growth of that partic-
ular crystal form of the complex. However, this fortuitous mode
of binding may actually be used to explain why GRFT, at least
in its dimeric form, possesses strong antiviral activity, whereas
jacalin (with one binding site per monomer), or b-prism II lectins
such as garlic lectin, despite their three sites, do not. A major
difference between GRFT and garlic lectin is the distance
between carbohydrate-binding sites on a monomer, 15 A˚ for
the former and a minimum of 22 A˚ for the latter. Thus, a single
molecule of nonamannoside cannot reach more than one site
on the garlic lectin (Ramachandraiah et al., 2003) but can easily
reach two or three on GRFT (Zio´lkowska et al., 2007a). If all
three GRFT sites were occupied by the terminal residues of a
single nonamannoside molecule, there would not be any more
branches left to provide crosslinking. However, with two sites
that are bound to terminal mannoses in the D1 and D2 branch
offering different electrostatic properties than the third one
(Figure 4B), the latter (and presumably weaker) site may provide1112 Structure 18, 1104–1115, September 8, 2010 ª2010 Elsevier Ltan anchoring point for other nonamannosides and thus initiate
crosslinking. The presence of two, almost identical, sites that
can be reached by a single molecule vastly increases the avidity
of binding, whereas the third site enhances crosslinking. Such
organization is unique to GRFT (other lectins mentioned above
either have fewer sites, or the existing sites cannot be spanned
by a single complex carbohydrate molecule). With dimers
allowing much more elaborate crosslinking patterns than mono-
mers, their antiviral activity is enhanced. While highly likely, this
interpretation will still require further verification through muta-
genesis studies that would involve modification of the individual
binding sites.
EXPERIMENTAL PROCEDURES
Mutagenesis and Protein Expression
All restriction enzymes where purchased from New England Biolabs. All
chemicals were obtained from American Bioanalytical, unless otherwise
stated. An expression vector containing the gene for GRFT downstream of
a hexahistidine tag and thrombin cleavage site (Giomarelli et al., 2006) was
used as a PCR template. The amplified cassette was cloned into pET-15b
expression vector in between the NcoI and XhoI sites. Standard site-directed
mutagenesis technique was used to mutate the thrombin cleavage sequence
to TEV cleavage sequence and to create all mutant forms of GRFT using muta-
genic primers (IDT), PfuUltra DNA polymerase (Stratagene), and DpnI (NEB).
All mutants were expressed in BL21(DE3) pLysS cells (Novagen) at 37C
and 226 rpm. Induction was initiated at optical density of 0.7 measured at
600 nm by addition of IPTG to a final concentration of 0.5 mM and continued
for 10 hr.
Protein Purification
Cell pellets were lysed in 50 mM Tris (pH 8.0), 500 mM NaCl, and 5% v/v
BugBuster 103 Protein Extraction Reagent (Merck), and the lysate was centri-
fuged at 17,000 rpm in a SS-34 rotor for 30 min. The supernatant was loaded
onto a Ni-NTA Superflow column (QIAGEN), equilibrated with five column
volumes of buffer A (20 mM Tris [pH 8.0], 100 mM NaCl). The column was
washed with buffer A and eluted with buffer A containing 250 mM imidazole.
TEV protease was added in 1:100 molar ratio of protease to eluted protein
and the sample was incubated at room temperature for 1 hr. At this stage,
two different strategies were used to complete the purification. For 1GS and
2GS proteins, the sample was loaded onto an amylose column equilibrated
with buffer A. The column was washed with buffer A and eluted with buffer A
containing 250mMmaltose. For 1GS-S and 1GS-SDNDY proteins, the sample
was heated at 50C for 10 min and then centrifuged at 12,000 rpm in a SS-34
rotor for 10 min. The supernatant was loaded onto a Ni-NTA column (QIAGEN)
equilibrated with buffer A and the flowthrough was collected. For all versions of
mGRFT, the purified protein was dialyzed against deionized, double-distilled
water overnight at 4C, and then concentrated.
Crystallization, Data Collection, and Refinement
All proteins were concentrated to 25 mg/ml. To create the complex with non-
amanoside, the carbohydrate was dissolved in water to a concentration of
10 mMand then titrated into a 1mg/ml sample of 1GS-S, 2 ml at a time, followed
by gentle mixing. The final molar ratio of nonamanoside to 1GS-S was 1.5:1.
The complex was subsequently concentrated to 25 mg/ml. Initial screens for
crystallization conditions were performed using a Phoenix liquid handling
robot (Art Robbins Instruments) in 96-well Intelli-Plates (Hampton Research),
with protein to well solution volumetric ratios of 1:2, 1:1, and, 2:1.
Initial crystallization conditions for the 1GS mutant were obtained from
EasyXtal Ammonium Sulfate crystallization suite (QIAGEN). These conditions
were optimized and diffraction quality crystals were grown in 0.1 M sodium
acetate (pH 4.0), 0.15 M ammonium sulfate, and 25% w/v PEG 3350 at 20C
by hanging drop vapor diffusion method. The protein and well solution were
mixed in 1:1 volumetric ratio. All other crystals of mGRFT mutants were
obtained directly from crystallization suites, with 1:1 volumetric ratio of protein
to well solution.d All rights reserved
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0.1 M cadmium chloride, and 30% w/v PEG 400 (QIAGEN EasyXtal Classics
Suite, #75). The 1GS-SDNDY crystals were grown in 0.1 M citric acid
(pH 3.5) and 3 M sodium chloride (QIAGEN EasyXtal Classics II, #7).
The 1GS-Sm9 crystallized under a variety of conditions from a number
of crystallization suites. Nevertheless, all crystals were isomorphous in the
space group I41. The highest resolution diffracting crystal was grown in
0.1 M mixture of imidazole, sodium cacodylate, MES, bis-tris (pH 6.5), 0.1 M
mixture of L-Na-glutamate, alanine, glycine, lysine HCl and serine, and 30%
w/v mixture of PEG MME 550 and PEG 20000 (Molecular Dimensions
Morpheus, #85).
All crystals were soaked for 3 min in a cryoprotectant solution consisting of
4:1 volumetric ration of mother liquor to 80% v/v glycerol and rapidly cooled in
a nitrogen stream (100 K). Data for the 2GS protein were collected with
a MAR345 dtb image plate detector mounted on a Rigaku MicroMax-007HF
generator operated at 40 kV and 30 mA. All other data were measured at
the SER-CAT beamline 22-ID, at the Advanced Photon Source, on a MAR
300CCD detector. The atomic resolution data for 1GS-Sm9 were measured
in two passes, with a low-resolution (30–3.0 A˚) pass and a high-resolution
(5.0–1.0 A˚) pass. The measured intensities for both passes were scaled and
merged together. All data were processed and scaled using the HKL3000
package (Minor et al., 2006). Initial phases were calculated by molecular
replacement method using the program Phaser (McCoy et al., 2007) and
a model derived from the structure of GRFT (PDB ID 2HYR), using residues
17–121 of chain A and 1–16 of chain B. The structures were refined with the
program Refmac5 (Murshudov et al., 1997) and rebuilt with Coot (Emsley
and Cowtan, 2004). Statistics of data processing and refinement are given in
Table 1.
Isothermal Titration Calorimetry
ITC experiments were performed using a MicroCal VP-ITC microcalorimeter
(MicroCal, Northampton, MA). The oligomannose sugars were diluted in the
same exact buffer (20 mM Tris, 150 mM NaCl [pH 7.5]) used to dialyze the
GRFT protein variants as well as gp120. The concentrations of the oligoman-
nose sugars were determined by oligosaccharide composition analysis by
HPAEC at the Complex Carbohydrate Research Center (CCRC, University of
Georgia, Athens, GA). The concentrations of all proteins were assessed by
amino acid analysis. In titrations with the oligomannose sugars, the protein
solutions were in the range of 0.1–0.3 mM, and the sugars in the concentration
range of 1–15 mM. In a typical titration experiment, the oligomannose sugar
was placed in the syringe injector and the GRFT protein solution was placed
in the calorimeter cell. In the experiments with HIV-1 glycoproteins, a protein
solution of gp120 was placed in the calorimeter cell at a concentration of
1.0 mM, and the GRFT proteins were loaded into the syringe injector at
a concentration of 0.175 mM. In all experiments, a total of 55 injections (5 ml
per injection) were made into a rapidly mixing solution (300 rpm), with 600 s
spacing between injections. The temperature was set at 25C and the refer-
ence power to 7 mcal/s.
The heats of dilution of the oligomannoses were accounted for by blank
titrations, where the oligomannoses were titrated into a buffer solution. After
subtracting these baseline thermograms from experimental thermograms,
the data were fit using Origin 5.0 nonlinear least-squares program supplied
by the manufacturer, and values for the binding enthalpy (DH) and the dissoci-
ation constant (Kd) were derived.
Differential Scanning Calorimetry
DSC experiments were performed using aMicroCal VP-DSCmicrocalorimeter
(MicroCal, Northampton, MA). The oligomannose sugars were diluted in the
same exact buffer (20 mM Tris, 150 mM NaCl [pH 7.5]) used to dialyze the
GRFT monomer variants. The concentrations of all proteins were assessed
by amino acid analysis. In a typical experimental format, buffer (20 mM Tris,
150 mM NaCl [pH 7.5]) was placed in both the reference and sample cells
and the calorimeter was allowed to cycle at a heating rate of 60C/hr, scanning
from 10C to 90C, with data recordings every 15 s. The calorimeter cells were
self-pressurized to approximately 30 psi of positive pressure to prevent evap-
oration of solutions at the higher temperatures. During the down-scan at 25C,
the buffer solution in the sample cell was quickly and efficiently replaced by
aGRFT protein solution (60 mM), positive pressurewas reapplied, and the calo-Structure 18, 1104–11rimetric cells were allowed to cycle between a total of six alternating up- and
down-scans from 10C to 90C to measure reversibility of the unfolding
process. Using Origin DSC Analysis software provided by the manufacturer,
themelting profiles of all samples were corrected for buffer effects by subtract-
ing the first up-scan of each experiment. To take into account the heat-
capacity changes between the native and denatured states of the protein,
a cubic baseline was extrapolated from pretransition and posttransition base-
lines and was subtracted from the melting profile. The resulting thermogram
was fit to a two-state melting model and the calorimetric transition enthalpy
(DHunf) was obtained from the numerical integration of the area under the
excess heat-capacity peak, and the midpoint of the transition was extrapo-
lated as the melting temperature.
Sedimentation Equilibrium Ultracentrifugation
Sedimentation equilibrium ultracentrifugation experiments were performed in
a Beckman Optima XL-A ultracentrifuge at 20C with absorbance optics at
280 nm. All protein samples were in a buffer containing 20 mM Tris (pH 8.0)
and 100 mM NaCl. Samples were spun in a Beckman An-60 Ti rotor using
1.2 cm two-sector charcoal-fillled Epon centerpieces with quartz windows
at speeds of 21,000, 25,000, and 30,000 rpm. Equilibrium was reached after
24 hr for each speed and verified by comparison with a second scan taken
2 hr later. All data were analyzed using the programs Sedfit and Sedphat
(Schuck, 2000) with a buffer density of 1.00293 g/cm3 and a buffer viscosity
of 0.01023 Poise as calculated using the program Sedenterp. Partial specific
volumes were also calculated with Sednterp to be 0.7164 (1GS), 0.7155
(2GS), 0.7142 (1GS-S), and 0.7134 (1GS-SDNDY) in units of g/cm3. All data
were fit using the simplex algorithm.
Whole-Cell anti-HIV Assays
An XTT-tetrazolium based assay was used to determine the anti-HIV activity of
GRFT against a T-tropic laboratory strain (HIV-1RF) in CEM-SS cells as previ-
ously described (Gulakowski et al., 1991). In brief, CEM-SS cells were main-
tained in RPMI 1640 media without phenol red and supplemented with 10%
fetal bovine serum (BioWhittaker), 2 mM L-glutamine (BioWhittaker), and
50 mg/mL gentamicin (BioWhittaker). Exponentially growing cells were washed
and resuspended in medium, and a 50 ml aliquot containing 5 3 103 cells was
added to individual wells of a 96-well round-bottommicrotiter plate containing
serial dilutions of GRFT, GRFT mutants, or AZT in a volume of 100 ml medium.
Stock supernatants of HIV-1RF were diluted in medium to yield sufficient
cytopathicity (80%–90% cell kill in 6 days), and a 50 ml aliquot was added to
appropriate wells. Plates were incubated for 6 days at 37C, then stained for
cellular viability using 2,3-bis-[2-methoxy-4-nitro-5-sulfophenyl]-2H-tetrazo-
lium-5-carboxanilide inner salt (XTT).
ACCESSION NUMBERS
Atomic coordinates and structure factors for 1GS, 2GS, 1GS-SDNDY, and
1GS-Sm9 versions of GRFT have been deposited in the Protein Data Bank
under accession codes 3LKY, 3LL0, 3LL1, and 3LL2, respectively.
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